FVC/DLCO identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD

Mortality GBD, Causes of Death C. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.

Article  Google Scholar 

Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399:2227–42.

Article  PubMed  Google Scholar 

Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013;1:73–83.

Article  PubMed  Google Scholar 

Carlin BW. COPD and associated comorbidities: a review of current diagnosis and treatment. Postgrad Med. 2012;124:225–40.

Article  PubMed  Google Scholar 

Blanco I, Tura-Ceide O, Peinado VI, Barbera JA. Updated perspectives on pulmonary hypertension in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:1315–24.

Article  PubMed  PubMed Central  Google Scholar 

Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducolone A, Ehrhart M, Oswald-Mammosser M. “Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med. 2001;164:219–24.

Article  CAS  PubMed  Google Scholar 

Thabut G, Dauriat G, Stern JB, Logeart D, Levy A, Marrash-Chahla R, Mal H. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531–6.

Article  PubMed  Google Scholar 

Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE, National Emphysema Treatment Trial G. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314–22.

Article  PubMed  Google Scholar 

Torres-Castro R, Gimeno-Santos E, Vilaro J, Roque-Figuls M, Moises J, Vasconcello-Castillo L, Orizaga T, Barbera JA, Blanco I. Effect of pulmonary hypertension on exercise tolerance in patients with COPD: a prognostic systematic review and meta-analysis. Eur Respir Rev. 2021;30:200321.

Article  PubMed  PubMed Central  Google Scholar 

Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:158–64.

Article  CAS  PubMed  Google Scholar 

Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, Barnett SD, Nathan SD. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med. 2010;104:1877–82.

Article  PubMed  Google Scholar 

Andersen KH, Iversen M, Kjaergaard J, Mortensen J, Nielsen-Kudsk JE, Bendstrup E, Videbaek R, Carlsen J. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31:373–80.

Article  PubMed  Google Scholar 

Gredic M, Blanco I, Kovacs G, Helyes Z, Ferdinandy P, Olschewski H, Barbera JA, Weissmann N. Pulmonary hypertension in chronic obstructive pulmonary disease. Br J Pharmacol. 2021;178:132–51.

Article  CAS  PubMed  Google Scholar 

Vizza CD, Hoeper MM, Huscher D, Pittrow D, Benjamin N, Olsson KM, Ghofrani HA, Held M, Klose H, Lange T, et al. Pulmonary hypertension in patients with COPD: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA). Chest. 2021;160:678–89.

Article  CAS  PubMed  Google Scholar 

Weitzenblum E. Chronic cor pulmonale. Heart. 2003;89:225–30.

Article  PubMed  PubMed Central  Google Scholar 

Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37:942–54.

Article  PubMed  Google Scholar 

Papamatheakis DG, Poch DS, Fernandes TM, Kerr KM, Kim NH, Fedullo PF. Chronic thromboembolic pulmonary hypertension: JACC focus seminar. J Am Coll Cardiol. 2020;76:2155–69.

Article  PubMed  Google Scholar 

Lurie A, Roche N. Obstructive sleep apnea in patients with chronic obstructive pulmonary disease: facts and perspectives. COPD. 2021;18:700–12.

Article  PubMed  Google Scholar 

Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducolone A, Ehrhart M, Kessler R, Weitzenblum E. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189–94.

Article  PubMed  Google Scholar 

Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev. 2015;24:642–52.

Article  PubMed  PubMed Central  Google Scholar 

Tsujimoto Y, Kumasawa J, Shimizu S, Nakano Y, Kataoka Y, Tsujimoto H, Kono M, Okabayashi S, Imura H, Mizuta T. Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults. Cochrane Database Syst Rev. 2022;5:CD012809.

PubMed  Google Scholar 

Zhang RF, Zhou L, Ma GF, Shao FC, Wu XH, Ying KJ. Diagnostic value of transthoracic Doppler echocardiography in pulmonary hypertension: a meta-analysis. Am J Hypertens. 2010;23:1261–4.

Article  CAS  PubMed  Google Scholar 

Charalampopoulos A, Raphael C, Gin-Sing W, Gibbs JS. Diagnosing and managing pulmonary hypertension. Practitioner. 2012;256(21–25):22–3.

Google Scholar 

Donato L, Giovanna Elisiana C, Giuseppe G, Pietro S, Michele C, Brunetti ND, Valentina V, Matteo DB, Maria Pia FB. Utility of FVC/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension. Intern Emerg Med. 2017;12:319–26.

Article  PubMed  Google Scholar 

Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum. 1992;35:765–70.

Article  CAS  PubMed  Google Scholar 

Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD Guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93:1488–502.

Article  PubMed  Google Scholar 

Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int. 2006;10:356–9.

Article  PubMed  Google Scholar 

Garcia AR, Piccari L. Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide. Curr Opin Pulm Med. 2022;28:343–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981;36:752–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J. 2013;41:1292–301.

Article  PubMed  Google Scholar 

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023–30.

Article  PubMed  Google Scholar 

Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 2011;140:19–26.

Article  PubMed  PubMed Central  Google Scholar 

Alter P, Orszag J, Kellerer C, Kahnert K, Speicher T, Watz H, Bals R, Welte T, Vogelmeier CF, Jorres RA. Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET. ERJ Open Res 2020; 6.

Rose L, Prins KW, Archer SL, Pritzker M, Weir EK, Misialek JR, Thenappan T. Survival in pulmonary hypertension due to chronic lung disease: influence of low diffusion capacity of the lungs for carbon monoxide. J Heart Lung Transplant. 2019;38:145–55.

Article  PubMed  Google Scholar 

Choi J, Sim JK, Oh JY, Lee YS, Hur GY, Lee SY, Shim JJ, Rhee CK, Min KH. Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D(LCO)) and forced expiratory volume in one second (FEV(1)). BMC Pulm Med. 2021;21:152.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takemura M, Mitsui K, Itotani R, Ishitoko M, Suzuki S, Matsumoto M, Aihara K, Oguma T, Ueda T, Kagioka H, Fukui M. Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:97–104.

Article  PubMed  PubMed Central  Google Scholar 

de Torres JP, O’Donnell DE, Marin JM, Cabrera C, Casanova C, Marin M, Ezponda A, Cosio BG, Martinez C, Solanes I, et al. Clinical and prognostic impact of low diffusing capacity for carbon monoxide values in patients with global initiative for obstructive lung disease I COPD. Chest. 2021;160:872–8.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif